Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 12,880 | 12,455 | 8,726 | 10,730 | 8,964 |
| Cost of Goods | 1,679 | 1,702 | 1,085 | 1,260 | 783 |
| Gross Profit | 11,201 | 10,753 | 7,641 | 9,470 | 8,181 |
| Operating Expenses | 128,749 | 138,511 | 114,355 | 134,767 | 111,775 |
| Operating Income | -116,869 | -127,056 | -106,629 | -125,037 | -102,811 |
| Other Income | 13,436 | 15,036 | 17,340 | 19,638 | 1,103,846 |
| Pre-tax Income | -103,433 | -112,020 | -89,289 | -105,399 | 1,001,035 |
| Income Tax | N/A | N/A | N/A | -8,876 | 53,120 |
| Net Income Continuous | -103,433 | -112,020 | -89,289 | -96,523 | 947,915 |
| Net Income | $-103,433 | $-112,020 | $-89,289 | $-96,523 | $947,915 |
| EPS Basic Total Ops | -1.78 | -1.93 | -1.55 | -1.65 | 16.65 |
| EPS Basic Continuous Ops | -1.78 | -1.93 | -1.55 | -1.65 | 16.65 |
| EPS Diluted Total Ops | -1.78 | -1.93 | -1.55 | -1.44 | 16.22 |
| EPS Diluted Continuous Ops | -1.78 | -1.93 | -1.55 | -1.45 | 16.22 |
| EPS Diluted Before Non-Recurring Items | N/A | -1.93 | -1.55 | -1.74 | 4.20 |
| EBITDA(a) | $-117,169 | $-128,217 | $-106,699 | $-129,286 | $-105,200 |